| Literature DB >> 32627665 |
Kenjiro Kunieda1,2, Yuichi Hayashi1, Megumi Yamada1, Masahiro Waza3, Tomonori Yaguchi1, Ichiro Fujishima2, Takayoshi Shimohata1.
Abstract
Swallowing function in long-term survivors with Creutzfeldt-Jakob disease (CJD) remains unknown. Herein, we demonstrated serial evaluation of swallowing function in a case with V180I genetic CJD (gCJD) using videofluoroscopic examination of swallowing (VF). A 69-year-old woman was admitted to our hospital because of bradykinesia and memory disturbances 4 months after the onset of symptoms. Neurological examination revealed dementia, bradykinesia and frontal signs. Diffusion-weighted MRI revealed bilateral cortical hyperintensity in the frontal, temporal, and parietal cortices, and PRNP gene analysis indicated a V180I mutation. Her dysphagia gradually progressed, and she received percutaneous gastrostomy 42 months after the onset. VF was performed at 27, 31, 39, and 79 months after the onset. Although bolus transport from oral cavity to pharynx gradually worsened and initiation of the pharyngeal swallow was gradually delayed, the pharyngeal swallowing function was preserved even at 72 months after onset. MRI revealed no apparent atrophy of brainstem, and single photon emission computed tomography showed preserved regional cerebral blood flow in the brainstem. These findings suggest that the pathophysiology of dysphagia in a long-term survivor of V180I gCJD is that of pseudobulbar palsy, likely owing to preserved brainstem function even in the akinetic mutism state.Entities:
Keywords: Genetic Creutzfeldt-Jakob disease; V180I mutation; dysphagia; long-term survivor; pseudobulbar palsy
Year: 2020 PMID: 32627665 PMCID: PMC7518740 DOI: 10.1080/19336896.2020.1787090
Source DB: PubMed Journal: Prion ISSN: 1933-6896 Impact factor: 3.931
Figure 1.Magnetic resonance imaging (MRI) and single photon emission computed tomography (SPECT) of the patient. (a) Images from follow-up diffusion-weighted MRI 79 months after the onset revealed that atrophy of the brainstem was not apparent. However, the severe cerebrum atrophy was found. (b) SPECT images at 79 months after the onset revealed decreased regional cerebral blood flow (rCBF) in the bilateral frontal and parieto-temporal lobes; however, rCBF was preserved in the brainstem and cerebellum. The eZIS analysis of 99mTc-ECD SPECT images revealed decreased rCBF. A higher Z-score indicates a lower rCBF. The Z-score of 2 to 6 is indicated by the green to red (lower rCBF) colour gradient.
Figure 2.Videofluoroscopic examination of swallowing (VF) of the patient.
Clinical course of patients with V180I genetic Creutzfeldt-Jakob disease except for patients with V180I/M232R combined mutation.
| Case No. | Author (y) | Onset of Age (yrs) | sex | Polymorphism at the codon 129 in the | Oral intake or Tube-feeding (Duration between onset and starting tube-fed) (m) | Duration of oral intake after onset (m) | Duration between onset and akinetic mutism (m) | Duration of oral intake after deteriorating akinetic mutism (m) | Cause of death (Duration between onset and death) (m) | MRI findings | Autopsy finding of brainstem | Evaluation of brainstem function | Evaluation of swallowing function |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Iwasaki (2019) [ | 87 | F | M/M | Oral intake | 22 | 18 | 4 | Alive | Cerebral hyperintensity | - | N.D. | N.D. |
| 2 | Iwasaki (2018) [ | 86 | F | M/M | Oral intake | 10 | - | N.D. | General weakness (10) | Cerebral hyperintensity | No apparent atrophy | N.D. | N.D. |
| 3 | Iwasaki (2017) [ | 78 | F | M/M | Gastrostomy (30) | 30 | 16 | 14 | Respiratory failure (33) | Cerebral hyperintensity | N.D. | N.D. | N.D. |
| 4 | Iwasaki (2017) [ | 76 | F | M/M | Gastrostomy | 34 | 17 | 17 | Alive | Cerebral hyperintensity | - | N.D. | N.D. |
| 5 | Iwasaki (2017) [ | 69 | F | M/M | Gastrostomy | 14 | 13 | 1 | Alive | Cerebral hyperintensity | - | N.D. | N.D. |
| 6 | Hayashi (2016, 2020) [ | 78 | F | M/M | Tube-fed (47) | 14 | 14 | 0 | Pneumonia | Cerebral hyperintensity | No apparent atrophy | N.D. | N.D. |
| 7 | Hayashi (2016) [ | 74 | F | M/V | Tube-fed (20) | 20 | 20 | 0 | Alive | Cerebral hyperintensity | - | N.D. | N.D. |
| 8 | Deguchi (2012) [ | 79 | F | N.D. | Oral intake | 60 | 18 | 42 | Alive | Cerebral hyperintensity | - | N.D. | N.D. |
| 9 | Iwasaki (2011) [ | 73 | F | M/M | Tube-fed | 22 | 22 | 0 | Respiratory failure (102) | Cerebral hyperintensity | No apparent atrophy | N.D. | N.D. |
| 10 | Current patient | 69 | F | M/M | Gastrostomy (42) | 83 | 12 | 71 | Alive | Cerebral hyperintensity | - | VE | VE, VF |
| AVG ± SD (range) | 77.0 ± 5.8 | F (10/10) | 29.3 ± 13.6 (14–47) | 30.9 ± 23.2 | 16.6 ± 3.3 | 16.6 ± 24.6 |
y: year, FILS: Food Intake LEVEL Scale, F: female, N.D.: not described, VE: videoendoscopic examination of swallowing, VF: videofluoroscopic examination of swallowing, AVG: average, SD: standard deviation